$7.5 million sales for Gedeon Richter

In the first quarter of this year, Gedeon Richter, the biggest Hungarian pharmaceutical producer, reported sales on the Romanian market worth 7.5 million dollars (over 6.4 million euros), 65% of which are drugs manufactured in the Targu Mures plant, according to the company”s quarterly report. Contacted by ZF, Gedeon Richter did not make any comment by the time the story was ready for print. The company is present on the Romanian market, both with production and import activities. Gedeon Richter began production activity in Romania in 1998, with the acquisition of the Armedica factory in Targu Mures. In September 2003, the Hungarian group merged with its subsidiary, forming Gedeon Richter Romania SA. The company has it own office, Richter Gedeon, which handles the portfolio of drugs imported from Hungary, particularly oral contraceptives. Products developed by Gedeon Richter Romania have entered the portfolio of the companies in the group over the last few years, so that the company started exports to Hungary, Russia and Poland. ZF